Domiciliary Nasal High Flow and Patient Outcomes in Chronic Hypercapnic Respiratory Failure in the United Kingdom

NAActive, not recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

January 26, 2024

Study Completion Date

January 26, 2024

Conditions
Chronic Hypercapnic Respiratory FailureChronic Obstructive Pulmonary DiseaseObesity Hypoventilation Syndrome (OHS)Nasal High FlowHealth-related Quality of Life
Interventions
DEVICE

Nasal High Flow

High flow nasal cannula (NHF) is a device that delivers warmed and humid air through a high air flow rate, through the nose. It is used as a non-invasive ventilatory approach, which is relatively comfortable, in the management of respiratory failure and has been investigated in several studies evaluating the outcomes as domiciliary treatment in patients with COPD.

Trial Locations (1)

NW3 2QG

Royal Free Hospital, Hampstead

All Listed Sponsors
collaborator

Fisher and Paykel Healthcare

INDUSTRY

collaborator

Royal Free Charity

UNKNOWN

lead

Royal Free Hospital NHS Foundation Trust

OTHER